Advertisement

memo - Magazine of European Medical Oncology

, Volume 3, Issue 3, pp 136–141 | Cite as

A review on biomolecular basis of the role of psychological stress in the development and progression of cancer

  • M. E. Sobhani
  • Md. A. W. MollaEmail author
  • Md. S. Rahman
Review

Summary

Over recent years there has been great progress in the scientific knowledge of health and well-being and the body's response to stress and the relationship to the development of cancer. This paper reviews the interrelationship between stress and cancer. The immune system is a specialized network whose activity is highly affected by stress. Stress activates the body's endocrine (hormone) system, which in turn can cause changes in the immune system, the body's defense against infection and disease including cancer. Under stressful conditions the body increases the production of catecholamines via sympathetic nervous system (SNS). Catecholamines suppress certain parts of the immune system and reduce the production of molecules that create inflammation. Catecholamines suppress the cell-mediated immunity (CMI) by reducing macrophages and Th production of type 1 cytokines (e.g. IL-12, TNF-α and IFN-γ), and by stimulating the release of immunosuppressive factors including IL-10 and TGF-α. Hormones associated with SNS activation may favour angiogenic mechanisms in human tumours. In response to chronic stress, catecholamines such as epinephrine and norepinephrine released from the sympathetic nervous system activate b-adrenergic receptors on tumour cells and enhance expression of vascular endothelial growth factor (VEGF), IL-6 and matrix metalloproteinases (MMPs). Stress can also activate the cAMP response element-binding (CREB) protein and create a hypoxic condition. CREB protein and hypoxia regulated genes, e.g. endothelin-1, adrenomedullin, Bcl-2 has been found that are involved in mitogenesis, tumour progression, angiogenesis and apoptosis. Psychosocial stressors and distress have been shown to have direct effects on intracellular processes that are implicated in cancer initiation. Stress may alter cellular DNA repair abilities, may increase the likelihood of retention of damaged DNA, and therefore increase the likelihood of development of malignant cells.

Keywords

Psychological stress Catecholamines Matrix metalloproteinases CREB protein Apoptosis Cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenberg SA, Karnofsky. Memorial lecture: the immunotherapy and gene therapy of cancer. J Clin Oncol, 10: 180–199, 1992PubMedGoogle Scholar
  2. Rabin BS, Cohen S, Ganguli R, Lysle DT, Cunnick JE. Bidirectional interaction between the central nervous system and immune system. Crit Rev Immunol, 9: 279–312, 1989PubMedGoogle Scholar
  3. Platzer C, Docke W, Volk H, Prosch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol, 105(1): 31–38, 2000CrossRefPubMedGoogle Scholar
  4. Woiciechowsky C, Schoning B, Lanksch WR, Volk, HD, Docke WD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med, 77(11): 769–780, 1999CrossRefPubMedGoogle Scholar
  5. Andersen B, Kiecolt-Glaser J, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol, 49: 389–404, 1994CrossRefPubMedGoogle Scholar
  6. Chen CC, David AS, Nunnerley H, et al. Adverse life events and breast cancer: case-control study. BMJ, 311: 1527–1530, 1995PubMedGoogle Scholar
  7. Duijts SF, Zeegers MP, Borne BV. The association between stressful life events and breast cancer risk: a metaanalysis. Int J Cancer, 107: 1023–1029, 2003CrossRefPubMedGoogle Scholar
  8. Geyer S. Life events prior to manifestation of breast cancer: a limited prospective study covering eight years before diagnosis. J Psychosom Res, 35: 355–363, 1991CrossRefPubMedGoogle Scholar
  9. Lillberg K, Verkasalo PK, Kaprio J, et al. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol, 157: 415–423, 2003CrossRefPubMedGoogle Scholar
  10. Levav I, Kohn R, Iscovich J, et al. Cancer incidence and survival following bereavement. Am J Public Health, 90: 1601–1607, 2000CrossRefPubMedGoogle Scholar
  11. Martikainen P, Valkonen T. Mortality after death of spouse in relation to duration of bereavement in Finland. J Epidemiol Commun Health, 50: 264–268, 1996CrossRefGoogle Scholar
  12. Giraldi T, Rodani MG, Cartei G, et al. Psychosocial factors and breast cancer: a 6-year Italian follow-up study. Psychother Psychosom, 66: 229–236, 1997CrossRefPubMedGoogle Scholar
  13. Penninx BW, Guralnik JM, Pahor M, et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst, 90: 1888–1893, 1998CrossRefPubMedGoogle Scholar
  14. Price MA, Tennant CC, Smith RC, et al. The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. Cancer, 91: 679–685, 2001CrossRefPubMedGoogle Scholar
  15. Lutgendorf SK, Costanzo ES. Psychoneuroimmunology and health psychology: an integrative model. Brain Behav Immun, 17: 225–232, 2003CrossRefPubMedGoogle Scholar
  16. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. A mechanism converting psychological stress into mononuclear cell activation. Proc Natl Acad Sci USA, 100: 1920–1925, 2003CrossRefPubMedGoogle Scholar
  17. Collins A, Frankenhaeuser M. Stress response in male and females engineering students. J Human Stress, 4: 43–48, 1978PubMedGoogle Scholar
  18. Frankenhaeuser M, von Wright MR, Collins A, von Wright J, Sedvall G, Swahn CG. Sex differences in psychoneuroendocrine reactions to examination stress. Psychosom Med, 40: 334–343, 1978PubMedGoogle Scholar
  19. Naliboff BD, Benten D, Solomon GF, Morley JE, Fahey JL, Bloom ET, MakinodanT, Gilmore SL. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med, 53: 121–132, 1991PubMedGoogle Scholar
  20. Pawlak CR, Jacobs, Mikeska E, Ochsmann S, Lombardi MS, Kavelaars A, Heijnen CJ, Schmidt R, Schedlowski M. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun, 13: 287–302, 1999CrossRefPubMedGoogle Scholar
  21. van Doornen LJ, van Blokland R. Serum-cholesterol: sex psychological correlates during rest and stress. J Psychosom Res, 31: 239–249, 1987CrossRefPubMedGoogle Scholar
  22. Danner SA, Endert E, Koster RW, Dunning AJ. Biochemical and circulatory parameters during purely mental stress. Acta Medica Scandinavica 209: 35–308, 1981Google Scholar
  23. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev, 52(4): 595–638, 2000PubMedGoogle Scholar
  24. Platzer C, Docke W, Volk H, Prosch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol, 105(1): 31–38, 2000CrossRefPubMedGoogle Scholar
  25. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk, HD, Docke WD. Sympathetic activation triggers systemic anti-inflammatory syndrome causing immunodepression. J Mol Med, 77(11): 769–780, 1998CrossRefGoogle Scholar
  26. Fredriksson JM, Lindquist JM, Bronnikov GE, et al. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta- adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem, 275: 13802–13811, 2000CrossRefPubMedGoogle Scholar
  27. Henney A, Ye S, Zhang B, Jormsjo S, Whatling C, Eriksson P, et al. Genetic diversity in the matrix metalloproteinase family: effects on function and disease progression. Ann NY Acad Sci, 902: 27–37, 2000CrossRefPubMedGoogle Scholar
  28. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metallo-proteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol, 2: 737–744, 2000CrossRefPubMedGoogle Scholar
  29. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPS and their regulators in ovarian cancer. Intl J Cancer, 58: 50–56, 1994CrossRefGoogle Scholar
  30. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Nat Cancer Inst, 94: 1134–1142, 2002PubMedGoogle Scholar
  31. Yang E, Bane CM, MacCallum RC, Kiecolt-Glaser JK, Malarkey WB, Glaser R. Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol, 133: 144–150, 2002CrossRefPubMedGoogle Scholar
  32. Wu W, Yamura T, Murakami K, Ogasawara M, Hayashi K, Murata J, et al. Involvement of TNFα in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress. Oncol Res, 11: 461–469, 1999PubMedGoogle Scholar
  33. Sood A, Landen C, Bhatty R, Thaker P, Lutgendorf S. Stress hormone mediated invasion of ovarian cancer cells. Psychosom Med, 65: A14, 2004Google Scholar
  34. Thaker P, Lloyd M, Jennings N, Felix E, Gershenson D, Newman R. Chronic stress promotes tumor growth and metastasis in ovarian carcinoma. Paper presented at Society of Gynecological Oncology 36th Annual Meeting, Miami Beach, FL, 2005Google Scholar
  35. Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res, 50: 6130–6138, 1990PubMedGoogle Scholar
  36. Flaxman BA, Harper RA. In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. J Invest Dermatol, 65: 52–59, 1975CrossRefPubMedGoogle Scholar
  37. Badino GR, Novelli A, Girardi C, et al. Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res, 33: 255–260, 1996CrossRefPubMedGoogle Scholar
  38. Vandewalle B, Revillion F, Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol, 116: 303–306, 1990CrossRefPubMedGoogle Scholar
  39. Marchetti B, Spinola PG, Pelletier G, et al. A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. J Steroid Biochem Mol Biol, 38: 307–320, 1991CrossRefPubMedGoogle Scholar
  40. Abramovitch R, Tavor E, Jacob-Hirsch J, et al. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res, 64: 1338–1346, 2004CrossRefPubMedGoogle Scholar
  41. Lang K, Drell TL, Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer, 112: 231–238, 2004CrossRefPubMedGoogle Scholar
  42. Jean, D, Bar-Eli M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem, 212: 19–28, 2000CrossRefPubMedGoogle Scholar
  43. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer, 88: 163–166, 2003CrossRefPubMedGoogle Scholar
  44. Freeland K, Boxer LM, Lachman D. The cyclic AMP response element in the BCL2 promoter confers inducibility by hypoxia in neuronal cells. Mol Brain Res, 92: 98–106, 2001CrossRefPubMedGoogle Scholar
  45. Wolter KG, Hsu Y, Smith CL, Mechushtan A, Xi X, Youle RJ. Movement of bax from cytosol to mitochondria during apoptosis. J Cell Biol, 139: 1281–1292, 1997CrossRefPubMedGoogle Scholar
  46. Setlow RB. Repair deficient human disorders and human cancer. Nature, 271: 713–717, 1978CrossRefPubMedGoogle Scholar
  47. Fox BH. Premorbid psychological factors as related to cancer incidence 1. J Behav Med, 1: 45–133, 1978CrossRefPubMedGoogle Scholar
  48. Kiecolt-Glaser JK, Stephens R, Lipitz P, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med, 8: 311–320, 1985CrossRefPubMedGoogle Scholar
  49. Glaser R, Thorn BE, Tarr KL, Kiecolt-Glaser JK, d'Ambrosio SM. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol, 4: 403–412, 1985CrossRefPubMedGoogle Scholar
  50. Fischman HK, Kelly DD. Cister chromatid exchanges induced by behavioural stress. Ann New York Acad Sci, 496: 426–435, 1987CrossRefGoogle Scholar
  51. Dhillon VS, Dhillon IK. Chromosome aberrations and sister chromatid exchange studies in patients with prostate cancer possible evidence of chromosome instability. Cancer Genet, 100: 143–147, 1998CrossRefGoogle Scholar
  52. Li GY, Yao KT. Glaser R. Sister chromatid exchange and nasopharyngeal carcinoma. Int J Cancer, 43; 613–618, 1989CrossRefPubMedGoogle Scholar
  53. Kanter P, Leister KJ, Tomei LK, Wenner PA, Wenner CE. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms. Biochem Biophys Res Commun, 118: 393–399, 1984CrossRefGoogle Scholar
  54. Tomei LD, Kanter P, Wenner CE. Inhibition of radiation induced apoptosis in vitro. Biochem Biophys Res Commun, 155: 324–331, 1988CrossRefPubMedGoogle Scholar
  55. Tomei LD, Kiecolt-Glaser JK, Kennedy S, Glaser R. Psychological stress and phorbol ester inhibition of radiation-induced apoptosis in human PBLs. Psychiat Res, 33: 59–71, 1990CrossRefGoogle Scholar
  56. Tomei LD, Noyes I, Blocker D, Holliday J, Glaser R. Epstein Barr virus dependent transformation of normal primary human skin epithelial cells. Nature, 329: 73–75, 1987CrossRefPubMedGoogle Scholar
  57. Zorrilla EP, Luborsky L, Mackay JR, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun, 15: 199–226, 2001CrossRefPubMedGoogle Scholar
  58. Irwin M, Daniels M, Smith TL, et al. Impaired natural killer cell activity during bereavement. Brain Behav Immun, 1: 98–104, 1987CrossRefPubMedGoogle Scholar
  59. Kiecolt-Glaser JK, Glaser R. Psychosocial moderators of immune function. Ann Behav Med, 9: 16–20, 1987CrossRefGoogle Scholar
  60. Ucker DS. Cytotoxic T-lymphocytes and glucocorticoids activate an endogenous suicide process in target cells. Nature, 327: 62–64, 1987CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  1. 1.Biotechnology and Genetic Engineering DisciplineKhulna UniversityKhulnaBangladesh

Personalised recommendations